Partnering opportunity

A druggable small molecule manufacturer looking for technology cooperation to develop meis protein detection kits

Summary

The company is a Turkish startup with the main focus on novel and high-level pharmaceutically active ingredients. They develop a protein inhibitor which is a target-based small molecule, druggable regulatory factor. It inhibits the transcription of genes regulated by a homeobox meis protein by modulating the activity of this protein. They are looking for technical cooperation to develop kits to be used in the determination of meis+ (producing meis proteins on their cells) patients.

Technical Specification or Expertise Sought

The company is looking for a partner experienced in developing and manufacturing diagnosis kits to detect meis protein from blood or cell samples in order to determine meis+ phenotype patients. The partner has to comply with EU "in vitro diagnostic medical device regulation 2017/746".

Partner sought

The company is looking for SMEs, R&D institutions and universities that can develop and manufacture meis protein detection assays in compliance with EU "in vitro diagnostic medical device regulation 2017/746".

Description

The company is a Turkish deep-tech startup established in 2018 by a genetics and bioengineering faculty member with the main focus on novel and high-level pharmaceutically active ingredients. Its team consists of molecular biologists, medical doctors and pharmacologists from academy and industry who are highly experienced in protein chemistry and drug development with a successful history of basic research and molecule design backed with many research grants and awards. The company develops meis inhibitor which is a target-based small molecule, druggable regulatory factor. Meis inhibitor inhibits the transcription of genes regulated by meis proteins by modulating the activity of meis protein. Meis proteins play a critical role in cell metabolism and are proven to be highly associated with diseases such as cancer, cardiovascular diseases, diabetes and obesity. The benefit presents to the targeted drug discovery researchers is providing insight into the biologic mechanisms of the non-communicable diseases. The molecule also has the potential of being used as a drug in its treatment. Meis inhibitors provide targeted therapy to patients by distinguishing between meis+ cancer types and disease-causing oncogene. Using meis inhibitors on meis+ phenotype patients increases the success of personalized treatment. There are no diagnostic tools available in the market that can determine meis+ patients therefore the company is looking for partnerships to develop meis+ patient diagnosis kits. The company is looking for a technical cooperation agreement to develop kits to be used in the determination of meis+ patients.

Advantages and innovations

Not available

Development stage

Concept stage

Intellectual Property Rights (IPR)

Patent(s) applied for but not yet granted


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company